Palvella Therapeutics, Inc. (PVLA) Financial Statements
Palvella Therapeutics, Inc. (PVLA) reported trailing twelve-month revenue of $1.4M (up 0.0% year on year) and net income of -$61.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PVLAPalvella Therapeutics, Inc.Follow PVLA — free
—
Price chart with a free account
- Market cap
- 1.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | 5.6 | 8.2 | 19.7 | 22.3 | 41.5 | 55.0 | 46.5 | 66.7 | 53.0 | 8.8 | 8.2 | 22.8 | 35.5 | |
| Operating income | -7.2 | -13.7 | -22.8 | -14.6 | -30.8 | -27.2 | -33.9 | -51.8 | -43.5 | -11.9 | -14.1 | -38.6 | -57.7 | |
| Pre-tax income | -9.8 | -13.9 | -22.6 | -16.5 | -27.1 | -25.5 | -37.1 | -45.7 | -33.3 | 18.7 | -17.4 | -41.7 | -61.7 | |
| Income tax | -0.0 | 0.2 | 0.2 | 1.1 | -0.3 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net income | -9.8 | -14.1 | -22.8 | -17.6 | -26.8 | -25.5 | -37.2 | -45.7 | -33.3 | 18.7 | -17.4 | -41.7 | -61.7 | |
| Diluted EPS ($) | -0.71 | -0.41 | -0.55 | -0.40 | -0.50 | -0.56 | -0.68 | -0.71 | — | 2.17 | -7.83 | -3.71 | -4.29 | |
| Diluted shares (mn) | — | — | — | — | — | — | — | 64.5 | — | 1.8 | 2.2 | 11.3 | — |
USD millions · SEC XBRL
Palvella Therapeutics, Inc. — questions
- What is Palvella Therapeutics, Inc.'s revenue?
- $1.4M over the twelve months to 2026-06-30, up 0.0% year on year, from its 10-Q and 10-K filings.
- What is Palvella Therapeutics, Inc.'s net income?
- -$61.7M over the twelve months to 2026-06-30.
- What are Palvella Therapeutics, Inc.'s diluted earnings per share?
- $-4.29 over the twelve months to 2026-06-30.
Every figure on this page comes from Palvella Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.